 |
|
Combination vaccine protects monkeys from ebola and Marburg viruses
February 27, 2008An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. Researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) report their results today (Feb. 26) at the 2008 ASM Biodefense and Emerging Diseases Research Meeting in Baltimore, MD.
"VLPs are one of the most promising candidates for protecting humans against Ebola and Marburg virus infections," says Dr. Kelly Warfield, a researcher at USAMRIID who presented the study. They could also be safer than other vaccine candidates.
Traditionally vaccines against viral diseases have consisted of whole viruses, either the one that causes the disease in a weakened or dead state (like the polio vaccine) or a genetically similar virus that does not usually cause disease but elicits a protective immune response. The problem with this approach is there is the risk, however small, of viral reactivation and infection.
"Since the VLP vaccine does not use a whole virus, there is no chance of infection," says Warfield, who notes that some VLP-based vaccines, such as the human papillomavirus (HPV) vaccine, are already on the market.
To create the vaccine, Warfield and her colleagues infected insect cells with specially engineered baculoviruses. The infected cells then produced VLPs for either Marburg or Ebola, depending on the baculovirus, which were then purified. They mixed the two together and vaccinated the monkeys with it.
"Following challenge with Ebola or Marburg virus, all the VLP-vaccinated monkeys survived challenge without clinical or laboratory signs of infection, while the control animals succumbed to the infection," says Warfield. "Based on their safety profile, immunogenicity and protective efficacy, the VLPs are a leading candidate for use as a filovirus vaccine in humans."
Additionally, Warfield discovered that vaccination with one strain of Marburg VLP produced protection against 3 different strains of the virus, which is surprising. Subunit vaccines (in which only part of the virus is used) had previously not been thought to confer broad-based immunity.
Researchers are currently working on scaling up the production process and hope to begin clinical trials in humans in a few years.
American Society for Microbiology
"Since the VLP vaccine does not use a whole virus, there is no chance of infection," says Warfield, who notes that some VLP-based vaccines, such as the human papillomavirus (HPV) vaccine, are already on the market.
To create the vaccine, Warfield and her colleagues infected insect cells with specially engineered baculoviruses. The infected cells then produced VLPs for either Marburg or Ebola, depending on the baculovirus, which were then purified. They mixed the two together and vaccinated the monkeys with it.
"Following challenge with Ebola or Marburg virus, all the VLP-vaccinated monkeys survived challenge without clinical or laboratory signs of infection, while the control animals succumbed to the infection," says Warfield. "Based on their safety profile, immunogenicity and protective efficacy, the VLPs are a leading candidate for use as a filovirus vaccine in humans."
Additionally, Warfield discovered that vaccination with one strain of Marburg VLP produced protection against 3 different strains of the virus, which is surprising. Subunit vaccines (in which only part of the virus is used) had previously not been thought to confer broad-based immunity.
Researchers are currently working on scaling up the production process and hope to begin clinical trials in humans in a few years.
American Society for Microbiology
Vaccine News and Current Vaccine Events RSSStudy firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism
In a case-control study, the presence of measles virus RNA was no more likely in children with autism and GI disturbances than in children with only GI disturbances.
Scientists uncover Ebola cell-invasion strategy
University of Texas Medical Branch at Galveston researchers have discovered a key biochemical link in the process by which the Ebola Zaire virus infects cells - a critical step to finding a way to treat the deadly disease produced by the virus.
Higher anaphylaxis rates after HPV vaccination: CMAJ study
The estimated rate of anaphylaxis in young women after human papillomavirus (HPV) vaccination was significantly higher - 5 to 20 fold - than that identified in comparable school-based vaccination programs.
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
Flu shot does not reduce risk of death
The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta.
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine.
Cell removal technique could lead to cheaper drugs
Researchers at the University of Edinburgh have pioneered a simple way to remove dead cells from cell cultures used to make protein-based drugs, which are increasingly prescribed to treat a range of illnesses.
UTMB researchers test new vaccine to fight multiple influenza strains
A universal vaccine effective against several strains of influenza has passed its first phase of testing, according to Dr. Christine Turley of the University of Texas at Galveston.
Cervical cancer prevention should focus on vaccinating adolescent girls
The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies.
China sees spike in rabies cases
A new Chinese study has reported a dramatic spike in rabies infections. The research, published today in the open access journal BMC Infectious Diseases, shows that in some provinces of China the number of human rabies cases has jumped dramatically since the new millennium.
More Vaccine News Articles
 | The Vaccine Book: Making the Right Decision for Your Child (Sears Parenting Library) by Robert Sears |
 | What Your Doctor May Not Tell You About Children's Vaccinations by Stephanie Cave In this book, Dr. Stephanie Cave explains vaccinationsthe pros and the cons. With detailed facts about each vaccination, as well as regulations and laws, this book provides easily understandable information to help parents make a knowledgeable, responsible choice about vaccinating their... |
 | Louder Than Words: A Mother's Journey in Healing Autism by Jenny McCarthy If someone you love is diagnosed with autism, LOUDER THAN WORDS is the first book you should read. One morning, Jenny McCarthy was having a cup of coffee when she sensed something was wrong. She ran into her two-year-old son Evan’s room and found him seizing. In that moment, Jenny went from being the mother of an average toddler to being in the midst of a medical odyssey. Doctor after doctor... |
 | Vaccine Safety Manual for Concerned Families and Health Practitioners: Guide to Immunization Risks and Protection by Neil Z. Miller The Vaccine Safety Manual is the world's most complete guide to immunization risks and protection. It includes pertinent information on every major vaccine: polio, tetanus, MMR, hepatitis A, B, HPV (cervical cancer), Hib, Flu, chickenpox, shingles, rotavirus, pneumococcal, meningococcal, RSV, DTaP, anthrax, smallpox, TB, and more. All of the information, including detailed vaccine safety and... |
 | Vaccinations: A Thoughtful Parent's Guide: How to Make Safe, Sensible Decisions about the Risks, Benefits, and Alternatives by Aviva Jill Romm • A balanced, comprehensive guide to routine childhood vaccinations that offers parents the information they need to make the right choices for their child.• Fairly examines the pros and cons of this highly charged issue. Deciding whether or when to vaccinate a child is one of the most important--and most difficult--health-care decisions a parent will ever make. The recent increase... |
 | Vaccination Against Smallpox (Great Minds Series) by Edward Jenner |
 | He's Not Autistic But...: How We Pulled Our Son From the Mouth of the Abyss by Tenna Merchent According to the U.S. Centers for Disease Control and Prevention, 1 in 166 children is born with autism. Tenna Merchent is only too familiar with this frightening statistic as she feared her own son might suffer from this devastating disorder. When her son was born, he seemed healthy. But by the time he was six weeks old, the infant cried for hours each evening if he wasn't constantly nursed. As... |
 | The Vaccine Guide: Risks and Benefits for Children and Adults by Randall Neustaedter The Vaccine Guide covers each disease and its vaccine, providing difficult-to-obtain facts about vaccine reactions. Also discussed are vaccine effectiveness, toxicity and adverse effects, legal requirements, alternatives, and the latest information on the threat of bioterrorism. New to this edition are topics of particular concern to adults, including smallpox and anthrax vaccines, flu shots, and... |
 | Do Vaccines Cause That?! A Guide for Evaluating Vaccine Safety Concerns by Martin G. Myers, Diego Pineda Do Vaccines Cause Autism, Asthma, Diabetes? Get straight, science-based answers to this and other questions about the safety of vaccines. In this book you will find the facts--no advocating hype or anti-vaccine propaganda. You will discover how to: * Balance the risks and benefits of immunizations for your child. * Recognize red flags that should raise alarms about vaccine- related information... |
 | Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy by David Kirby Avoiding hyperbole while writing about a possible medical catastrophe is no easy task, but David Kirby has created a fine balance of investigative and personal detail in Evidence of Harm. Combining stories from the parents of autistic children with reports, speeches and studies from researchers, pediatricians and government officials, he creates a picture that is as terrifying as anything dreamed... |
| © 2008 BrightSurf.com |